Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

17.76 +0.69 (+4.04%)

Streaming Delayed Price Updated: 1:00 PM EDT, Jun 17, 2026 Add to My Watchlist

Price and Volume

Volume	681,115
Open	17.16
Bid (Size)	17.74 (200)
Ask (Size)	17.77 (200)
Prev. Close	17.07
Today's Range	17.16 - 17.95
52wk Range	8.195 - 22.50
Shares Outstanding	47,147,781
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket ↗

June 08, 2026

href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in pre-market trading. The company recently announced a 1-for-20 reverse stock split.The shares of Marvell...

Via Benzinga

A Nurix Therapeutics (NRIX) Insider Sold 5,394 Shares for $90,000 ↗

May 06, 2026

Nurix Therapeutics, a biotech innovator in targeted cancer therapies, reported a notable insider sale amid strong one-year stock gains.

Via The Motley Fool

Performance

YTD	-1.7%	-1.7%
1 Month	+14.5%	+14.5%
3 Month	+14.7%	+14.7%
6 Month	-5.7%	-5.7%
1 Year	+49.1%	+49.1%

More News

Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026

April 22, 2026

From Nurix Therapeutics, Inc.

Via GlobeNewswire

Nurix Therapeutics Inc (NASDAQ:NRIX) Reports Mixed Q4 2025 Results, Highlights Key Clinical Milestone ↗

January 28, 2026

Via Chartmill

Nurix Stock Falls After-Hours After Wider Q3 Loss; Oppenheimer Sees FDA Support For Bexo, Retail Buys The Dip ↗

October 09, 2025

Via Stocktwits

Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting

March 23, 2026

From Nurix Therapeutics, Inc.

Via GlobeNewswire

Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million ↗

February 22, 2026

Via The Motley Fool

Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120% ↗

February 22, 2026

Via The Motley Fool

Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year ↗

February 22, 2026

Via The Motley Fool

Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 ↗

February 22, 2026

Via The Motley Fool

Biotech Fund Doubles Down With $49 Million Scholar Rock Buy as Shares Climb 26% ↗

February 22, 2026

Via The Motley Fool

A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗

January 15, 2026

Via Chartmill

Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge

December 24, 2025

From Equity Insider

Via GlobeNewswire

13 Analysts Have This To Say About Nurix Therapeutics ↗

November 04, 2025

Via Benzinga

Nurix Therapeutics (NASDAQ: NRIX) Stock Soars as Pivotal Phase 2 Study for Bexobrutideg Ignites Investor Confidence

October 22, 2025

Via MarketMinute

Breaking Down Nurix Therapeutics: 5 Analysts Share Their Views ↗

October 10, 2025

Via Benzinga

Nurix Therapeutics Posts Downbeat Q3 Results, Joins Orthopediatrics, Levi Strauss And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

October 10, 2025

Via Benzinga

Why Applied Digital Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket ↗

October 10, 2025

Via Benzinga

Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday ↗

October 10, 2025

Via Benzinga

NURIX THERAPEUTICS INC (NASDAQ:NRIX) Misses Q3 2025 Estimates, Shares Drop ↗

October 09, 2025

Via Chartmill

6 Analysts Assess Nurix Therapeutics: What You Need To Know ↗

July 31, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 17, 2025

Via Benzinga

Which stocks are moving after the closing bell on Thursday? ↗

July 17, 2025

Via Chartmill

A Glimpse Into The Expert Outlook On Nurix Therapeutics Through 5 Analysts ↗

July 14, 2025

Via Benzinga

Amazon To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday ↗

July 10, 2025

Via Benzinga

Frequently Asked Questions

Is Nurix Therapeutics, Inc. - Common stock publicly traded?

Yes, Nurix Therapeutics, Inc. - Common stock is publicly traded.

What exchange does Nurix Therapeutics, Inc. - Common stock trade on?

Nurix Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market

What is the ticker symbol for Nurix Therapeutics, Inc. - Common stock?

The ticker symbol for Nurix Therapeutics, Inc. - Common stock is NRIX on the Nasdaq Stock Market

What is the current price of Nurix Therapeutics, Inc. - Common stock?

The current price of Nurix Therapeutics, Inc. - Common stock is 17.76

When was Nurix Therapeutics, Inc. - Common stock last traded?

The last trade of Nurix Therapeutics, Inc. - Common stock was at 06/17/26 01:00 PM ET

What is the market capitalization of Nurix Therapeutics, Inc. - Common stock?

The market capitalization of Nurix Therapeutics, Inc. - Common stock is 837.34M

How many shares of Nurix Therapeutics, Inc. - Common stock are outstanding?

Nurix Therapeutics, Inc. - Common stock has 837M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.